You are here: Industry Insights > depression

News List

“All-powerful Drug” of Allergan: Botox Pushed Clinical Trial, MDD Clinical Protocol Postponed PharmaSources/Zhulikou431
January 09, 2019
Phase III clinical trial of Allergan’s Botox for major depressive disorder (MDD) will be pushed to the second half of 2019 (H2 2019), said the spokesperson of the company recently.
How to Handle Holiday Stressors drugs
December 26, 2018
While others are decking the halls, many people find the holidays trigger anxiety and depression.Stress can arise from financial strain, dealing with difficult relatives or.....
Mergers Among Biotech Stocks Could Rise In 2019 firstwordpharma
December 25, 2018
According to analysts at RBC Capital Markets, Sarepta Therapeutics, Sage Therapeutics and Loxo Oncology are the most likely takeover targets among biotechnology firms in 2019, reported Investor's Business Daily. Sarepta is working on a gene therapy in a m
Magic mushroom drug could be depression breakthrough, says FDA pharmaphorum
December 19, 2018
The liberty cap mushroom, notoriously used illegally as a psychoactive drug, could be the inspiration for a new therapy for depression according to the US drug regulator.
Limiting Social Media May Improve Psychological Well-Being drugs
December 03, 2018
Limiting social media use to 30 minutes per day may lead to significant improvement in well-being, according to a study published in the December issue of the Journal of Social and Clinical Psychology......
Depression Is a Risk for Teens, Adults With Epilepsy drugs
December 03, 2018
Teens and adults with epilepsy are at increased risk for depression and should undergo regular screening, two new studies say.In one study, researchers evaluated nearly....
Genetic Analysis Shows Higher BMI May Up Risk for Depression drugs
November 30, 2018
Being overweight likely plays a causal role in the development of depression, even in the absence of other health problems, according to a study published online Nov. 13 in the International Journal of Epidemiology......
Genomic study directly links depression to obesity pharmaceutical-technology
November 14, 2018
A genomic study conducted by the University of Exeter, UK, and the University of South Australia has found that higher body mass index (BMI) has a strong psychological association with depression, including in the absence of other health problems.
FDA panel slams Alkermes’ opioid-based depression drug fiercebiotech
November 05, 2018
It has been a long and difficult road for Alkermes’ new depression drug, and Thursday’s advisory committee vote won’t make it any easier. The panel voted 21-2 against recommending...
FDA staff spotlight big—but expected—issues on Alkermes' depression drug fiercebiotech
November 02, 2018
The FDA raised significant—but expected—concerns about Alkermes’ major depressive disorder drug ALKS-5461 in briefing documents released (PDF) ahead of an advisory committee

Previous page 1 2 3 4 5 6 7 8 9 10 Next page